What is MR DNA?
Molecular Research (MR DNA) is a provider of Next-Gen Sequencing and Bioinformatics Services, specializing in collaborative service pricing for various sequencing platforms including Illumina, 454, and Ion Torrent. The company offers a comprehensive suite of bioinformatics and collaborative analysis services, aiming to support researchers in accelerating their path to publication. MR DNA's expertise spans microbiome research, including 16S RNA pyrosequencing, metagenomics, transcriptomes, and genomes, utilizing proprietary methods like the bacterial tag-encoded FLX amplicon pyrosequencing (bTEFAP®) approach for microbial diversity evaluation. Additionally, the company leverages 15 years of experience in developing novel molecular diagnostic assays, with ongoing efforts in next-generation diagnostic assay development in partnership with its clients.
How much funding has MR DNA raised?
MR DNA has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in MR DNA
PPP
Public-Private Partnership
What's next for MR DNA?
The recent strategic investment in MR DNA, occurring within the context of large-scale late-stage funding, suggests the company is poised for significant scaling and expansion. This capital injection is likely to fuel advancements in their sequencing technologies, bioinformatics platforms, and the development of new molecular diagnostic tools. MR DNA's focus on cost-effective solutions for microbiome and genome sequencing, coupled with its diagnostic assay development, positions it for growth in both the research and clinical markets. Future strategic initiatives may involve expanding service offerings, enhancing computational infrastructure, and forging new partnerships to solidify its market position.
See full MR DNA company page
